SELECTIVE NEURODEGENERATION, NEUROPATHOLOGY AND SYMPTOM PROFILES IN HUNTINGTON'S DISEASE

被引:0
|
作者
Waldvogel, Henry J. [1 ,2 ]
Thu, Doris [3 ]
Hogg, Virginia [2 ,4 ]
Tippett, Lynette [2 ,4 ]
Faull, Richard L. M. [1 ,2 ]
机构
[1] Univ Auckland, Dept Anat Radiol, Fac Med & Hlth Sci, Auckland 1, New Zealand
[2] Univ Auckland, Ctr Brain Res, Auckland 1, New Zealand
[3] Ecole Polytech Fed Lausanne, Brain Mind Inst, Lausanne, Switzerland
[4] Univ Auckland, Dept Psychol, Auckland, New Zealand
来源
TANDEM REPEAT POLYMORPHISMS: GENETIC PLASTICITY, NEURAL DIVERSITY AND DISEASE | 2012年 / 769卷
关键词
CELL-CELL INTERACTIONS; CAG REPEAT LENGTH; BASAL GANGLIA; MOUSE MODEL; NEUROTROPHIC FACTOR; PROJECTION NEURONS; CLINICAL-FEATURES; DIFFERENTIAL LOSS; STRIATAL NEURONS; CEREBRAL-CORTEX;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Huntington's disease (HD) is an autosomal dominant inherited neurodegenerative disease caused by a CAG repeat expansion in exon 1 of the Huntington gene (HD) also known as IT15. Despite the disease being caused by dysfunction of a single gene, expressed as an expanded polyglutamine in the huntingtin protein, there is a major variability in the symptom profile of patients with Huntington's disease as well as great variability in the neuropathology. The symptoms vary throughout the course of the disease and vary greatly between cases. These symptoms present as varying degrees of involuntary movements, mood, personality changes, cognitive changes and dementia. To determine whether there is a morphological basis for this symptom variability, recent studies have investigated the cellular and neurochemical changes in the striatum and cerebral cortex in the human brain to determine whether there is a link between the pathology in these regions and the symptomatology shown by individual cases. These studies together revealed that cases showing mainly mood symptom profiles correlated with marked degeneration in the strio-somal compartment of the striatum, or in the anterior cingulate gyrus of the cerebral cortex. In contrast, in cases with mainly motor symptoms neurodegeneration was especially marked in the primary motor cortex with variable degeneration in both the striosomes and matrix compartments of the striatum. These studies suggest that the variable degeneration of the striatum and cerebral cortex correlates with the variable profiles of Huntington's disease.
引用
收藏
页码:141 / 152
页数:12
相关论文
共 50 条
  • [31] Olfactory neuropathology in Alzheimer's disease: a sign of ongoing neurodegeneration
    Son, Gowoon
    Jahanshahi, Ali
    Yoo, Seung-Jun
    Boonstra, Jackson T.
    Hopkins, David A.
    Steinbusch, Harry W. M.
    Moon, Cheil
    BMB REPORTS, 2021, 54 (06) : 295 - 304
  • [32] A comparison of Huntington disease and Huntington disease-like 2 neuropathology
    Rudnicki, Dobrila D.
    Pletnikova, Olga
    Vonsattel, Jean-Paul G.
    Ross, Christopher A.
    Margolis, Russell L.
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2008, 67 (04): : 366 - 374
  • [33] Postmortem neuropathology in early Huntington disease
    Hedreen, John C.
    Berretta, Sabina
    White III, Charles L.
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2024, 83 (05): : 294 - 306
  • [34] CELLULAR AND REGIONAL GENE EXPRESSION CHANGES IN HUMAN HUNTINGTON'S DISEASE CORTEX CORRELATE WITH SYMPTOM PROFILES
    Thu, D.
    Oorschot, D.
    Tippett, L.
    Hogg, V.
    Waldvogel, H.
    Faull, R.
    Luthi-Carter, R.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2010, 81 : A2 - A2
  • [35] Quality of Symptom Management in Patients with Huntington's Disease
    Browne, P.
    Reynolds, C.
    O'Brien, M.
    Counihan, T.
    NEUROTHERAPEUTICS, 2014, 11 (01) : 216 - 217
  • [36] Disentangling the Connection Between Neurodevelopment and Neurodegeneration in Huntington's Disease
    Estevez-Fraga, Carlos
    Tabrizi, Sarah J.
    MOVEMENT DISORDERS, 2022, 37 (12) : 2343 - 2344
  • [37] Cognitive phenotype and neurodegeneration associated with Tau in Huntington's disease
    Martinez-Horta, Saul
    Perez-Perez, Jesus
    Perez-Gonzalez, Rocio
    Sampedro, Frederic
    Horta-Barba, Andrea
    Campolongo, Antonia
    Rivas-Asensio, Elisa
    Puig-Davi, Arnau
    Pagonabarraga, Javier
    Kulisevsky, Jaime
    ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2024, 11 (05): : 1160 - 1171
  • [38] Nonapoptotic neurodegeneration in a transgenic mouse model of Huntington's disease
    Turmaine, M
    Raza, A
    Mahal, A
    Mangiarini, L
    Bates, GP
    Davies, SW
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (14) : 8093 - 8097
  • [39] The Role of MicroRNAs in Neurodegeneration: Insights from Huntington's Disease
    Mansour, Reda M.
    Shaker, Abanoub A. S.
    Abulsoud, Ahmed I.
    Mageed, Sherif S. Abdel
    Ashraf, Alaa
    Elsakka, Elsayed G. E.
    Dahab, Mohammed. I.
    Sadek, Mohamed M.
    Awad, Farah A.
    Lutfy, Radwa H.
    Elimam, Hanan
    Faraag, Ahmed H. I.
    Nassar, Yara A.
    Ali, Mohamed A.
    Mohammed, Osama A.
    Abdel-Reheim, Mustafa Ahmed
    Doghish, Ahmed S.
    MOLECULAR NEUROBIOLOGY, 2025,
  • [40] Cystathionine γ-lyase deficiency mediates neurodegeneration in Huntington’s disease
    Bindu D. Paul
    Juan I. Sbodio
    Risheng Xu
    M. Scott Vandiver
    Jiyoung Y. Cha
    Adele M. Snowman
    Solomon H. Snyder
    Nature, 2014, 509 : 96 - 100